Ultragenyx Pharmaceutical
RARE
#4710
Rank
S$2.46 B
Marketcap
S$25.47
Share price
-2.69%
Change (1 day)
-50.93%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) Fails to deliver data

Key failure to deliver metrics for Ultragenyx Pharmaceutical:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Ultragenyx Pharmaceutical (RARE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Ultragenyx Pharmaceutical (RARE) - since 2014

Volume in USD (price x number of shares), data since 2014

Ultragenyx Pharmaceutical (RARE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026S$0.51 M-94.92%
2025S$10.15 M35.75%
2024S$7.48 M-48.37%
2023S$14.48 M344.12%
2022S$3.26 M-64.77%
2021S$9.26 M-20.49%
2020S$11.64 M-3.02%
2019S$12.01 M-75.7%
2018S$49.42 M-12.01%
2017S$56.16 M-14.47%
2016S$65.66 M-56.5%
2015S$0.15 B326.02%
2014S$35.43 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Lexicon Pharmaceuticals
LXRX
S$1.11 MS$11.66 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$1.36 MS$7.89 M๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.10 BS$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$6.91 MS$14.14 M๐Ÿ‡บ๐Ÿ‡ธ USA